Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Goodwill: 2021-2025

Historic Goodwill for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $22.9 million.

  • Xeris Biopharma Holdings' Goodwill changed negligibly% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $22.9 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Goodwill is $22.9 million, which was down 0.00% from $22.9 million recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Goodwill registered a high of $22.9 million during Q4 2021, and its lowest value of $22.9 million during Q4 2021.
  • In the last 3 years, Xeris Biopharma Holdings' Goodwill had a median value of $22.9 million in 2025 and averaged $22.9 million.